Sakditad “Tew” Saowapa and Chalothorn “Sai” Wannaphut
Jun 5, 2025, 10:49
Incidence and Survival Outcomes of Breast Cancer Subtypes in the United States
Sakditad “Tew” Saowapa, Oncologist at UI Holden Comprehensive Cancer Center, shared a post on X:
“Proud to present our work at the 2025 ASCO.
Annual Meeting, now in JCO!
Incidence and survival outcomes of breast cancer subtypes in the United States.
- Studied US breast cancer (BC) subtypes (2000–2021).
- Incidence: Ductal (79.1%), lobular (10.9%), mucinous (2.8%), medullary (0.7%).
- Survival: Metastatic BC (APC 3.5%), lobular (HR 1.58) had worse outcomes.
- Need targeted interventions for tougher subtypes.”
Chalothorn “Sai” Wannaphut, Internal Medicine Resident at the John A. Burns School of Medicine, reshared the post on X, adding:
“Honored to contribute to this important study!
Grateful for the guidance of my mentor, Dr. Arya Roy in shaping this work.”
Incidence and survival outcomes of breast cancer subtypes in the United States.
Authors: Sakditad Saowapa, Chalothorn Wannaphut, Jayalekshmi Jayakumar, Ben Ponvilawan, Safa Saadat Afridi, Varsha Gupta, and Arya Mariam Roy.
You can read the full article on Journal of Clinical Oncology.
More posts featuring Sakditad “Tew” Saowapa.
Arya Mariam Roy
Arya Roy
ASCO
Ben Ponvilawan
Breast Cancer
cancer
Chalothorn “Sai” Wannaphut
Chalothorn Wannaphut
clinical oncology
fight against cancer
Global fight against cancer
Jayalekshmi Jayakumar
John A. Burns School of Medicine
OncoDaily
Oncology
Safa Saadat Afridi
Sakditad “Tew” Saowapa
Sakditad Saowapa
UI Holden Comprehensive Cancer Center
United States
Varsha Gupta
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 26, 2025, 19:30
Jun 26, 2025, 17:54
Jun 26, 2025, 17:47
Jun 26, 2025, 17:29